BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1439 related articles for article (PubMed ID: 25493333)

  • 1. T cell antigen receptor recognition of antigen-presenting molecules.
    Rossjohn J; Gras S; Miles JJ; Turner SJ; Godfrey DI; McCluskey J
    Annu Rev Immunol; 2015; 33():169-200. PubMed ID: 25493333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid and small-molecule display by CD1 and MR1.
    Van Rhijn I; Godfrey DI; Rossjohn J; Moody DB
    Nat Rev Immunol; 2015 Oct; 15(10):643-54. PubMed ID: 26388332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How TCRs bind MHCs, peptides, and coreceptors.
    Rudolph MG; Stanfield RL; Wilson IA
    Annu Rev Immunol; 2006; 24():419-66. PubMed ID: 16551255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen recognition by CD1d-restricted NKT T cell receptors.
    Godfrey DI; Pellicci DG; Patel O; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Semin Immunol; 2010 Apr; 22(2):61-7. PubMed ID: 19945889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predisposed αβ T cell antigen receptor recognition of MHC and MHC-I like molecules?
    Eckle SB; Turner SJ; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2013 Oct; 25(5):653-9. PubMed ID: 23993410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.
    Beckman EM; Porcelli SA; Morita CT; Behar SM; Furlong ST; Brenner MB
    Nature; 1994 Dec; 372(6507):691-4. PubMed ID: 7527500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Third Way: Progress on pathways of antigen processing and presentation by CD1.
    Lawton AP; Kronenberg M
    Immunol Cell Biol; 2004 Jun; 82(3):295-306. PubMed ID: 15186261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.
    Beringer DX; Kleijwegt FS; Wiede F; van der Slik AR; Loh KL; Petersen J; Dudek NL; Duinkerken G; Laban S; Joosten A; Vivian JP; Chen Z; Uldrich AP; Godfrey DI; McCluskey J; Price DA; Radford KJ; Purcell AW; Nikolic T; Reid HH; Tiganis T; Roep BO; Rossjohn J
    Nat Immunol; 2015 Nov; 16(11):1153-61. PubMed ID: 26437244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR recognition of peptide/MHC class II complexes and superantigens.
    Sundberg EJ; Deng L; Mariuzza RA
    Semin Immunol; 2007 Aug; 19(4):262-71. PubMed ID: 17560120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAITs, MR1 and vitamin B metabolites.
    Birkinshaw RW; Kjer-Nielsen L; Eckle SB; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2014 Feb; 26():7-13. PubMed ID: 24556396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.